1. FRI0116 Impact of prior biologic use on treatment response in patients with rheumatoid arthritis receiving adalimumab in routine clinical care: results from the passion study. (12th June 2018) Authors: Van den Bosch, F.; Wassenberg, S.; Zueger, P.; Kalabic, J.; Wu, M.; Monastiriakos, K.; Ostor, A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LB0001 EFFICACY AND SAFETY OF UPADACITINIB VERSUS PLACEBO AND ADALIMUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NON-BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PsA-1): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL. (13th June 2020) Authors: Mcinnes, I.; Anderson, J.; Magrey, M.; Merola, J. F.; Liu, Y.; Kishimoto, M.; Jeka, S.; Pacheco Tena, C. F.; Wang, X.; Chen, L.; Zueger, P.; Pangan, A.; Behrens, F. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0223 EFFICACY AND SAFETY OF UPADACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (SELECT-PSA-2): A DOUBLE-BLIND, RANDOMIZED CONTROLLED PHASE 3 TRIAL. (2nd June 2020) Authors: Genovese, M. C.; Lertratanakul, A.; Anderson, J.; Papp, K.; Tillett, W.; Van den Bosch, F.; Tsuji, S.; Dokoupilova, E.; Keiserman, M.; Wang, X.; Zhong, S.; Zueger, P.; Pangan, A.; Mease, P. J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0090 Evaluation of the use of ultrasound to manage patients with rheumatoid arthritis over time: results from the corrona registry. (12th June 2018) Authors: Pappas, D.A.; Saunders, K.C.; Etzel, C.J.; Hua, D.W.; Deering, K.; Zueger, P.; Garg, V. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 906 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0294 Association of enthesitis with achievement of normal quality of life and clinical response in patients with non-radiographic axial spondyloarthritis treated with adalimumab. (12th June 2018) Authors: Mease, P.J.; Van den Bosch, F.; Kiltz, U.; Zueger, P.; Chen, K.; Wu, M.; Anderson, J.K. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1011 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. THU0190 Clinical outcomes among rheumatoid arthritis patients receiving adalimumab who did or did not participate in the patient support program: a subanalysis of the passion study. (12th June 2018) Authors: Ostor, A.; Wassenberg, S.; Zueger, P.; Kalabic, J.; Wu, M.; Lagunes Galindo, I.; Van den Bosch, F. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 314 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0375 IMPROVEMENTS IN GLOBAL FUNCTIONING AND HEALTH-RELATED QUALITY OF LIFE AND THEIR ASSOCIATION WITH DISEASE ACTIVITY AND FUNCTIONAL IMPROVEMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS TREATED WITH UPADACITINIB: RESULTS FROM THE SELECT-AXIS 1 TRIAL. (2nd June 2020) Authors: Kiltz, U.; Sieper, J.; Deodhar, A.; Zueger, P.; Song, I. H.; Chen, N.; Van der Heijde, D. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 420 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗